Phenytoin prevents seizures by blocking sodium channels in the brain, specifically by locking them in an inactive state so they can’t fire repeatedly. This makes it one of the oldest and most widely used anticonvulsant medications, approved for tonic-clonic (grand mal) seizures, temporal lobe seizures, and seizures related to neurosurgery. Understanding how it works also helps explain why it requires such careful dosing and monitoring compared to many other medications.
Blocking Sodium Channels in the Brain
Your brain cells communicate through electrical signals. When a nerve cell fires, tiny gates called voltage-gated sodium channels open, allowing sodium to rush in and generate an electrical impulse. Normally, these channels open, close, and reset in a fraction of a second. During a seizure, groups of neurons fire rapidly and uncontrollably, with sodium channels cycling open again and again.
Phenytoin binds to these sodium channels while they’re in their inactive (closed) state and holds them there longer than usual. This is called “use-dependent” blocking: the more frequently a channel fires, the more likely phenytoin is to catch it in that inactive window and lock onto it. Neurons firing at normal rates are barely affected because their channels spend less time in the inactive state. But neurons firing at the rapid, abnormal rates seen during a seizure are selectively slowed down. The drug enters the channel pore through two routes: through small openings that connect to the surrounding cell membrane, and through the channel’s own internal gate. This selective targeting is what allows phenytoin to suppress seizure activity without broadly sedating normal brain function.
Why Dosing Is Unusually Tricky
Most medications follow a simple rule: double the dose, double the drug level in your blood. Phenytoin doesn’t work this way. Your liver breaks down phenytoin using a process that becomes saturated at therapeutic doses, meaning the liver’s capacity to clear the drug maxes out within the normal dosing range. Once that happens, even a small increase in dose can cause a disproportionately large jump in blood levels.
This is why phenytoin requires regular blood tests. The target range for total phenytoin in the blood is 10 to 20 mcg/mL, with free (unbound) phenytoin between 1 and 2 mcg/mL. Staying within that window matters because the margin between an effective dose and a toxic one is narrow. A person stable at 15 mcg/mL might jump to 30 mcg/mL with a dose increase that would barely register with most other drugs.
What Happens When Levels Get Too High
Phenytoin toxicity follows a predictable pattern tied to blood concentration. Within the therapeutic range of 10 to 20 mcg/mL, some people experience mild involuntary eye movements (nystagmus), especially when looking to the side. As levels climb above 20 mcg/mL, symptoms progress to unsteady walking and coordination problems. Higher levels bring slurred speech, confusion, and drowsiness. Because of the saturated metabolism described above, toxicity can creep up unexpectedly if doses are adjusted without checking blood levels.
Protein Binding and Who Needs Extra Monitoring
About 90% of phenytoin in your bloodstream rides attached to a protein called albumin. Only the remaining unbound fraction actually reaches the brain and does anything. Standard blood tests measure total phenytoin (bound plus unbound), so anything that lowers your albumin or bumps phenytoin off its binding site changes how those numbers should be interpreted.
Several conditions lower albumin levels: liver cirrhosis, kidney disease, severe burns, pregnancy, malnutrition, and cancer. In these situations, more phenytoin floats free in the blood even though the total level looks normal or low. A total reading of 12 mcg/mL might seem fine, but if albumin is low, the free drug concentration could be in the toxic range. Kidney failure and high bilirubin levels also displace phenytoin from albumin, as do several common medications including valproate (another seizure drug), some anti-inflammatory painkillers, and certain antibiotics. For people with any of these conditions, measuring free phenytoin levels directly gives a much more accurate picture.
Interactions With Other Medications
Phenytoin is a strong activator of liver enzymes, specifically CYP2C9, CYP2C19, and CYP3A4. These enzymes break down a huge number of other medications, so phenytoin can dramatically reduce the effectiveness of drugs you take alongside it. The list is extensive: oral contraceptives, blood thinners, certain immunosuppressants, corticosteroids, and many others. In transplant patients, for example, phenytoin has been shown to slash levels of immunosuppressive drugs so severely that it puts organ grafts at risk of rejection.
The interaction cuts both ways. Other drugs can raise or lower phenytoin levels by competing for the same liver enzymes or by displacing it from albumin. This bidirectional complexity is one of the main reasons phenytoin has gradually been replaced by newer seizure medications in many clinical settings, though it remains widely used because it’s effective and inexpensive.
Common Side Effects
Gum overgrowth is one of phenytoin’s most distinctive side effects, occurring at a notably high rate among users. The drug triggers an inflammatory response in gum tissue that leads fibroblasts (the cells responsible for building connective tissue) to produce excess structural material, causing the gums to thicken and sometimes grow over the teeth. Good oral hygiene and regular dental care can help manage it, but some people eventually need to switch medications.
Other common side effects include dizziness, fatigue, skin rashes, and coarsening of facial features with long-term use. Phenytoin can also cause excess hair growth and acne, side effects that are particularly bothersome for younger patients.
Effects on Bones With Long-Term Use
People who take phenytoin for years face a real risk of weakened bones. The drug speeds up the breakdown of vitamin D in the liver, which reduces your body’s ability to absorb calcium from food. There’s also evidence that phenytoin directly interferes with the cells that build new bone. Over time, this combination can lead to thinning bones and an increased fracture risk. If you’re on phenytoin long-term, vitamin D and calcium supplementation along with periodic bone density checks can help catch problems early.